Influence of the COVID-19 Pandemic on Clinical Trial Discontinuation in Anesthesiology: Cross-sectional Analysis
JMIR Perioperative Medicine · 05.04.2022 · 5 (1) · e34936
DOI: 10.2196/34936 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift JMIR Perioperative Medicine, online erschienen am 05.04.2022. Verfasst von Brett D Traxler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Office of Medical Student Research, College of Osteopathic Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
The COVID-19 pandemic drastically altered perioperative medical practice owing to safety concerns, postponing elective or nonemergent procedures, supply chain shortages, and reallocating perioperative staff to care for patients with COVID-19. However, the impact of the pandemic on the conduct on anesthesiology clinical research is unknown.
Objective
The primary objective was to quantify the magnitude of the COVID-19 pandemic’s impact on anesthesiology clinical research.
Methods
We performed a systematic search using ClinicalTrials.gov to identify clinical trials related to the practice of anesthesiology. We screened trials with status updates from January 1, 2020, through October 1, 2021, to capture trials potentially affected by the COVID-19 pandemic by the time of our search. Investigators screened for relevant studies and extracted trial characteristics along with the reason for discontinuation reported on the clinical trial registry.
Results
A total of 823 clinical trials met inclusion criteria, and 146 clinical trials were discontinued within the designated date range. In total, 24 (16.4%) of the 146 clinical trials were halted explicitly owing to the COVID-19 pandemic. A significant association existed between trial enrollment numbers and the likelihood of discontinuation due to the COVID-19 pandemic, as larger trials were more likely to be disrupted (z=–2.914, P=.004).
Conclusions
The COVID-19 pandemic is reportedly associated with the discontinuation of anesthesiology-related clinical trials. With the uncertain course of the COVID-19 pandemic, developing anesthesia trial protocols to help minimize social interaction and prevent premature trial disruption are imperative.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Office of Medical Student Research, College of Osteopathic Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States.
- Office for Research Development and Scholarly Activity, School of Community Medicine, University of Oklahoma, Tulsa, OK, United States.
- Department of Psychiatry and Behavioral Sciences, College of Osteopathic Medicine, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States.
ORCID-Profile: Brett D Traxler, Brayden M Rucker, Mary C Greenough, Nicholas B Sajjadi, Micah Hartwell
Zitieren
APA
Traxler, B. D., Rucker, B. M., Greenough, M. C., Sajjadi, N. B., & Hartwell, M. (2022). Influence of the COVID-19 Pandemic on Clinical Trial Discontinuation in Anesthesiology: Cross-sectional Analysis. JMIR Perioperative Medicine, 5(1), e34936. https://doi.org/10.2196/34936
Vancouver
Traxler BD, Rucker BM, Greenough MC, Sajjadi NB, Hartwell M. Influence of the COVID-19 Pandemic on Clinical Trial Discontinuation in Anesthesiology: Cross-sectional Analysis. JMIR Perioperative Medicine. 2022;5(1):e34936. doi:10.2196/34936
BibTeX
@article{Traxler2022,
author = {Traxler, Brett D and Rucker, Brayden M and Greenough, Mary C and Sajjadi, Nicholas B and Hartwell, Micah},
title = {Influence of the COVID-19 Pandemic on Clinical Trial Discontinuation in Anesthesiology: Cross-sectional Analysis},
journal = {JMIR Perioperative Medicine},
year = {2022},
volume = {5},
number = {1},
pages = {e34936},
doi = {10.2196/34936}
}
EUVIMED